Kuehn Law, PLLC is investigating whether officers and directors of iRhythm Technologies breached fiduciary duties by misrepresenting the Zio AT monitor as a real-time device for high-risk patients. The lawsuit claims insiders falsely promoted the product's market potential, causing iRhythm's stock price to trade at artificially inflated levels. Investors who bought shares before November 5, 2021, are encouraged to contact the law firm to protect their rights. This case highlights concerns about transparency and accurate disclosure in medical device markets.
Evercore ISI raised Ross Stores' price target to $276, suggesting a 12.5% upside from its current $245.36 price. The boost reflects strong expectations for Q2, with projected revenues of $6.10 billion (up 10.7%) and earnings per share of $1.92 (up 23...
Fabrinet is set to report strong Q3 2026 earnings with revenue forecasted at about $1.276 billion, a 41% increase year-over-year, driven by demand in Telecom and Data Center sectors. Earnings per share are expected to rise 45% to $3.81, reflecting ro...
Jernigan Capital, a REIT specializing in financing self-storage facilities, saw its stock rise over 11% to $24.00, reaching a new 52-week high. Analysts have a consensus "Moderate Buy" rating with an average 12-month price target of $27.50, suggestin...
CrowdStrike, a leading cybersecurity firm, has seen its stock price increase by 85% year-to-date, reaching a market cap over $220 billion. Investment firm Cowen & Co. reiterated a "Buy" rating and raised the price target to $235, citing strong financ...
In Q2, corporate earnings grew 50.4%, the fastest pace since mid-2021, driven largely by Alphabet and Amazon, which contributed 18.4 percentage points to this growth. Alphabet posted a massive 216% earnings per share beat, though adjusting for unreal...
